Arcutis Biotherapeutics, Inc. (ARQT)
23.88
+0.50
(+2.16%)
USD |
NASDAQ |
Sep 11, 16:00
23.89
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price : 23.88 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 23.63 | 24.18 | 23.55 | 23.88 | 2.045M |
| Sep 10, 2026 | 23.70 | 23.84 | 23.25 | 23.38 | 1.785M |
| Sep 09, 2026 | 24.05 | 24.46 | 23.74 | 23.84 | 2.315M |
| Sep 08, 2026 | 24.84 | 25.13 | 24.09 | 24.39 | 4.560M |
| Sep 04, 2026 | 23.27 | 24.02 | 23.27 | 23.90 | 1.632M |
| Sep 03, 2026 | 24.13 | 24.13 | 23.47 | 23.66 | 1.122M |
| Sep 02, 2026 | 23.95 | 24.45 | 23.40 | 23.85 | 1.951M |
| Sep 01, 2026 | 23.79 | 24.11 | 23.54 | 23.75 | 1.102M |
| Aug 31, 2026 | 23.75 | 24.07 | 23.21 | 23.97 | 1.523M |
| Aug 28, 2026 | 24.60 | 24.88 | 23.74 | 23.78 | 1.536M |
| Aug 27, 2026 | 24.95 | 25.15 | 24.60 | 24.87 | 2.205M |
| Aug 26, 2026 | 24.85 | 25.50 | 24.45 | 25.14 | 1.911M |
| Aug 25, 2026 | 25.01 | 25.34 | 24.74 | 24.86 | 1.186M |
| Aug 24, 2026 | 24.80 | 25.21 | 24.49 | 24.78 | 1.128M |
| Aug 21, 2026 | 25.49 | 25.67 | 24.73 | 25.08 | 2.159M |
| Aug 20, 2026 | 26.50 | 26.56 | 24.53 | 25.35 | 3.289M |
| Aug 19, 2026 | 27.00 | 27.19 | 26.37 | 26.46 | 1.025M |
| Aug 18, 2026 | 25.51 | 26.71 | 25.49 | 26.54 | 1.972M |
| Aug 17, 2026 | 26.20 | 26.34 | 25.51 | 25.61 | 1.710M |
| Aug 14, 2026 | 25.39 | 26.24 | 25.28 | 26.19 | 1.110M |
| Aug 13, 2026 | 26.57 | 26.65 | 25.76 | 25.83 | 1.586M |
| Aug 12, 2026 | 26.62 | 26.62 | 25.92 | 26.28 | 1.184M |
| Aug 11, 2026 | 26.24 | 26.82 | 25.82 | 26.23 | 1.050M |
| Aug 10, 2026 | 24.93 | 25.95 | 24.76 | 25.92 | 2.095M |
| Aug 07, 2026 | 26.65 | 26.88 | 25.26 | 25.29 | 2.449M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Insmed, Inc. | 129.41 |
| Emergent BioSolutions, Inc. | 6.23 |
| Exelixis, Inc. | 56.12 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
Price Related Metrics
| PE Ratio | 115.33 |
| PS Ratio | 6.870 |
| Price to Book Value | 13.60 |
| Price to Free Cash Flow | 81.41 |
| Earnings Yield | 0.87% |
| Market Cap | 3.000B |
| Operating PE Ratio | 93.05 |
| Normalized PE Ratio | 115.11 |